Atlas Trials

A Safety and Dose-Determining Study of CMX001 In Infants With Neonatal Herpes Simplex Virus (HSV) Infection Involving the Central Nervous System (CNS Disease)

Clinical trial NCT01610765 · WITHDRAWN

Trial details

NCT number
NCT01610765
Sponsor
University of Alabama at Birmingham
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Herpes Simplex Virus
Start date
2016-01-01
Primary completion
2017-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.